CareLit · DOI-Nachweis · Pneumologie
An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF)
DOI 10.1055/s-0039-3403253
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Flume, R Fischer Biner, DG Downey, C Brown, M Jain, R Fischer, C de Boeck, D Campbell, X Wang, N Ahluwalia, CA Owen, C Wainwright
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF)
Zitieren
Zitierempfehlung
P Flume, R Fischer Biner, DG Downey, C Brown, M Jain, R Fischer, C de Boeck, D Campbell, X Wang, N Ahluwalia, CA Owen, C Wainwright (2020) An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF). Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403253
Mit CareLit weiterarbeiten